Efalizumab (Anti-Integrin aL / ITGAL / CD11a)

Efalizumab (Anti-Integrin aL / ITGAL / CD11a) is a humanized IgG1 monoclonal antibody directed against CD11a, the alpha subunit of human leukocyte-function-associated antigen type 1 (LFA-1), with immunosuppressant activity. MW: 145.5 kD.
Supplier Selleck Chemicals
Product # A2421
Sku # A2421-1mg*25
Pricing 1mg*25, $2970.00
Feedback